LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY

The Lancet

Volumn 330, Issue 8564, 1987, Pages 871-874

  Gruppo italiano per lo studio della streptochi nasi, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE;

ACUTE HEART INFARCTION; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CLOT LYSIS; DRUG ADMINISTRATION; HEART; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; THERAPY;

AGED; CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFUSIONS, INTRAVENOUS; ITALY; MALE; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; SEX FACTORS; STREPTOKINASE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 84913702444     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)91369-9     Document Type: Article

References (16)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Introduction. Coronary thrombolysis: Second chance therapy. Maximizing the advantage
3. A randomized placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction
4. Thrombolysis in the treatment of acute transmural myocardial infarction
5. Coronary thrombolysis
6. Streptokinase in acute myocardial infarction
7. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report
8. Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
9. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity
10. Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2
11. Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
12. Improved left ventricular function and survival after acute myocardial infarction with intravenous streptokinase. a double blind trial with and without concomitant intravenous propranolol
13. Randomized factorial trial of high-dose intravenous streptokinase, or oral aspirin, and of intravenous heparin in acute myocardial infarction
14. Coronary angioplasty following rt-PA in acute myocardial infarction A report from the Thrombolysis In Myocardial Infarction (TIMI) trial
15. GISSI Ricerca del Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico Progetto generale e sottoprogetti Risultati della fase acuta e del follow-up